Golexanolone affords sustained microglia and astrocytes activation improvement in a rat model of Parkinson’s disease

Gergana Mincheva, Maria A. Pedrosa, Mar Martínez-García Vázquez, Lola Vazquez, Thomas P. Blackburn, Magnus Doverskog, Marta Llansola, Vicente Felipo

Open source

DOI
10.3389/fimmu.2025.1654664
Published
2025-09-03
Container
Frontiers in Immunology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2025.1654664,
  title = {Golexanolone affords sustained microglia and astrocytes activation improvement in a rat model of Parkinson’s disease},
  author = {Gergana Mincheva and Maria A. Pedrosa and Mar Martínez-García Vázquez and Lola Vazquez and Thomas P. Blackburn and Magnus Doverskog and Marta Llansola and Vicente Felipo},
  year = {2025},
  journal = {Frontiers in Immunology},
  doi = {10.3389/fimmu.2025.1654664},
  url = {https://doi.org/10.3389/fimmu.2025.1654664}
}

RIS

TY  - JOUR
TI  - Golexanolone affords sustained microglia and astrocytes activation improvement in a rat model of Parkinson’s disease
AU  - Gergana Mincheva
AU  - Maria A. Pedrosa
AU  - Mar Martínez-García Vázquez
AU  - Lola Vazquez
AU  - Thomas P. Blackburn
AU  - Magnus Doverskog
AU  - Marta Llansola
AU  - Vicente Felipo
PY  - 2025
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2025.1654664
UR  - https://doi.org/10.3389/fimmu.2025.1654664
ER  - 

APA

Mincheva, G., Pedrosa, M. A., Vázquez, M. M., Vazquez, L., Blackburn, T. P., Doverskog, M., Llansola, M., & Felipo, V. (2025). Golexanolone affords sustained microglia and astrocytes activation improvement in a rat model of Parkinson’s disease. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2025.1654664

Source records